| For: | Zelber-Sagi S, Buch A, Yeshua H, Vaisman N, Webb M, Harari G, Kis O, Fliss-Isakov N, Izkhakov E, Halpern Z, Santo E, Oren R, Shibolet O. Effect of resistance training on non-alcoholic fatty-liver disease a randomized-clinical trial. World J Gastroenterol 2014; 20(15): 4382-4392 [PMID: 24764677 DOI: 10.3748/wjg.v20.i15.4382] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i15/4382.htm |
| Number | Citing Articles |
| 1 |
Hirokazu Takahashi, Kazuhiko Kotani, Kenichi Tanaka, Yuichiro Egucih, Keizo Anzai. Therapeutic Approaches to Nonalcoholic Fatty Liver Disease: Exercise Intervention and Related Mechanisms. Frontiers in Endocrinology 2018; 9 doi: 10.3389/fendo.2018.00588
|
| 2 |
Robson Damasceno de Lima, Renan Fudoli Lins Vieira, Vitor Rosetto Muñoz, Amandine Chaix, Ana Paula Azevedo Macedo, Gabriel Calheiros Antunes, Maíra Felonato, Renata Rosseto Braga, Susana Castelo Branco Ramos Nakandakari, Rafael Calais Gaspar, Adelino Sanchez Ramos da Silva, Dennys Esper Cintra, Leandro Pereira de Moura, Rania A. Mekary, Eduardo Rochete Ropelle, José Rodrigo Pauli. Time-restricted feeding combined with resistance exercise prevents obesity and improves lipid metabolism in the liver of mice fed a high-fat diet. American Journal of Physiology-Endocrinology and Metabolism 2023; 325(5) doi: 10.1152/ajpendo.00129.2023
|
| 3 |
Audrey Thorp, Jonathan G. Stine. Exercise as Medicine: The Impact of Exercise Training on Nonalcoholic Fatty Liver Disease. Current Hepatology Reports 2020; 19(4) doi: 10.1007/s11901-020-00543-9
|
| 4 |
Noha M. Gamil, Habiba A. Elsayed, Esraa T. Salah, Heba A. Mostafa, Riham A. El-Shiekh, Heba R. Ghaiad, Hebatollah E. Eitah. Decoding the mechanistic basis of liver–muscle communication in health and disease. Naunyn-Schmiedeberg's Archives of Pharmacology 2026; 399(8) doi: 10.1007/s00210-026-05015-3
|
| 5 |
Stephan C. Bischoff, William Bernal, Srinivasan Dasarathy, Manuela Merli, Lindsay D. Plank, Tatjana Schütz, Mathias Plauth. ESPEN practical guideline: Clinical nutrition in liver disease. Clinical Nutrition 2020; 39(12) doi: 10.1016/j.clnu.2020.09.001
|
| 6 |
Juanjuan Wen, Haiyan Zhou, Lirong Zeng. Comment on: Effect of exercise-based interventions in nonalcoholic fatty liver disease: A systematic review with meta-analysis. Digestive and Liver Disease 2023; 55(11) doi: 10.1016/j.dld.2023.07.022
|
| 7 |
Ángel Brea, Xavier Pintó, Juan F. Ascaso, Mariano Blasco, Ángel Díaz, Pedro González-Santos, Antonio Hernández-Mijares, Teresa Mantilla, Jesús Millán, Juan Pedro-Botet. Enfermedad del hígado graso no alcohólico, asociación con la enfermedad cardiovascular y tratamiento (II). Tratamiento de la enfermedad del hígado graso no alcohólico. Clínica e Investigación en Arteriosclerosis 2017; 29(4) doi: 10.1016/j.arteri.2016.06.002
|
| 8 |
Amit Kumar Singh, Navneet Kaur, Sushant Kaushal, Rahul Tyagi, Deepali Mathur, Madhava Sai Sivapuram, Kashinath Metri, Sridhar Bammidi, Vivek Podder, Shweta Modgil, Radhika Khosla, Kiran Sharma, Abhilasha Anand, Neeru Malik, VidhyaSagar Boroiah, Raghuram Nagarathna, Hongasandra R. Nagendra, Akshay Anand. Partitioning of radiological, stress and biochemical changes in pre-diabetic women subjected to Diabetic Yoga Protocol. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(4) doi: 10.1016/j.dsx.2019.07.007
|
| 9 |
Mathias Plauth, William Bernal, Srinivasan Dasarathy, Manuela Merli, Lindsay D. Plank, Tatjana Schütz, Stephan C. Bischoff. ESPEN guideline on clinical nutrition in liver disease. Clinical Nutrition 2019; 38(2) doi: 10.1016/j.clnu.2018.12.022
|
| 10 |
Katherine T. Brunner, Cameron J. Henneberg, Robert M. Wilechansky, Michelle T. Long. Nonalcoholic Fatty Liver Disease and Obesity Treatment. Current Obesity Reports 2019; 8(3) doi: 10.1007/s13679-019-00345-1
|
| 11 |
Hao Wang, Qianqian Ma, Youpeng Chen, Ling Luo, Junzhao Ye, Bihui Zhong. Optimized strategy among diet, exercise, and pharmacological interventions for nonalcoholic fatty liver disease: A network meta‐analysis of randomized controlled trials. Obesity Reviews 2024; 25(6) doi: 10.1111/obr.13727
|
| 12 |
Hee-Tae Roh, Ju-Yong Bae. Exercise as a Metabolic Therapy for MASLD: Beyond Weight Loss Toward Sustainable Exercise Strategies. Medicina 2026; 62(4) doi: 10.3390/medicina62040784
|
| 13 |
Vicente Artola Arita, Manuel Castro Cabezas, Juliana Alexandra Hernández Vargas, Silvia Juliana Trujillo-Cáceres, Nathalie Mendez Pernicone, Lara Anne Bridge, Hamidreza Raeisi-Dehkordi, Carmen A. W. Dietvorst, Ruben Dekker, Julieth Pilar Uriza-Pinzón, Mohamed Tawfik, Kirsten A. Berk, Jo Massoels, Stan Driessen, Maarten E. Tushuizen, Adriaan G. Holleboom, Diederick E. Grobbee, Oscar H. Franco, Sara Beigrezaei. Effects of Mediterranean diet, exercise, and their combination on body composition and liver outcomes in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials. BMC Medicine 2025; 23(1) doi: 10.1186/s12916-025-04320-7
|
| 14 |
Amedeo Lonardo, Juan Pablo Arab, Marco Arrese. Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management. Advances in Therapy 2021; 38(5) doi: 10.1007/s12325-021-01690-1
|
| 15 |
Nermeen N. El-Agroudy, Anica Kurzbach, Roman N. Rodionov, John O’Sullivan, Michael Roden, Andreas L. Birkenfeld, Dominik H. Pesta. Are Lifestyle Therapies Effective for NAFLD Treatment?. Trends in Endocrinology & Metabolism 2019; 30(10) doi: 10.1016/j.tem.2019.07.013
|
| 16 |
Mathias Plauth. Comprehensive Guide to Hepatitis Advances. 2023; doi: 10.1016/B978-0-323-98368-6.00004-5
|
| 17 |
Jonathan G. Stine, Michelle T. Long, Kathleen E. Corey, Robert E. Sallis, Alina M. Allen, Matthew J. Armstrong, David E. Conroy, Daniel J. Cuthbertson, Andres Duarte-Rojo, Kate Hallsworth, Ingrid J. Hickman, Matthew R. Kappus, Shelley E. Keating, Christopher J.A. Pugh, Yaron Rotman, Tracey G. Simon, Eduardo Vilar-Gomez, Vincent Wai-Sun Wong, Kathryn H. Schmitz. American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver disease. Hepatology Communications 2023; 7(4) doi: 10.1097/HC9.0000000000000108
|
| 18 |
Shira Zelber-Sagi, Federico Salomone, Ilana Kolodkin-Gal, Noam Erez, Assaf Buch, Hanny Yeshua, Muriel Webb, Zamir Halpern, Oren Shibolet. Protective role of soluble receptor for advanced glycation end-products in patients with non-alcoholic fatty liver disease. Digestive and Liver Disease 2017; 49(5) doi: 10.1016/j.dld.2017.01.148
|
| 19 |
Gasser El-Azab, Mohamed Akl Rady, Medhat Assem, Hanaa Nagdy. Hepatogenous diabetes in the era of precision medicine: diagnosis, management, and future directions. Clinical and Experimental Medicine 2026; 26(1) doi: 10.1007/s10238-026-02112-8
|
| 20 |
Anne Fougerat, Alexandra Montagner, Nicolas Loiseau, Hervé Guillou, Walter Wahli. Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease. Cells 2020; 9(7) doi: 10.3390/cells9071638
|
| 21 |
Emilio Molina‐Molina, Raquel Lunardi Baccetto, David Q.‐H. Wang, Ornella de Bari, Marcin Krawczyk, Piero Portincasa. Exercising the hepatobiliary‐gut axis. The impact of physical activity performance. European Journal of Clinical Investigation 2018; 48(8) doi: 10.1111/eci.12958
|
| 22 |
Hans-Theo Schon, Ralf Weiskirchen. Exercise-Induced Release of Pharmacologically Active Substances and Their Relevance for Therapy of Hepatic Injury. Frontiers in Pharmacology 2016; 7 doi: 10.3389/fphar.2016.00283
|
| 23 |
Chao-Rui Hu, Chuan-Fei Zeng, Huan Li, Mingliang Wei, Shi-Qian Liu, Lian-Yun Li, Yong Xiao, Min Wu, Ming-Kai Chen. Multi-omics analysis of the gut-liver axis revealed the effects of different exercise interventions in NAFLD mice. BMC Microbiology 2026; 26(1) doi: 10.1186/s12866-026-04711-7
|
| 24 |
Shira Zelber‐Sagi, Shahar Azar, Alina Nemirovski, Muriel Webb, Zamir Halpern, Oren Shibolet, Joseph Tam. Serum levels of endocannabinoids are independently associated with nonalcoholic fatty liver disease. Obesity 2017; 25(1) doi: 10.1002/oby.21687
|
| 25 |
Mohammad Habibullah, Khaleed Jemmieh, Amr Ouda, Mohammad Zulqurnain Haider, Mohammed Imad Malki, Abdel-Naser Elzouki. Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1291501
|
| 26 |
Elena Buzzetti, Audrey Linden, Lawrence MJ Best, Angela M Madden, Danielle Roberts, Thomas J G Chase, Suzanne C Freeman, Nicola J Cooper, Alex J Sutton, Dominic Fritche, Elisabeth Jane Milne, Kathy Wright, Chavdar S Pavlov, Brian R Davidson, Emmanuel Tsochatzis, Kurinchi Selvan Gurusamy. Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis. Cochrane Database of Systematic Reviews 2021; 2021(6) doi: 10.1002/14651858.CD013156.pub2
|
| 27 |
Mariana Verdelho Machado. Aerobic Exercise in the Management of Metabolic Dysfunction Associated Fatty Liver Disease. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; doi: 10.2147/DMSO.S304357
|
| 28 |
Bo Kyung Koo, Donghee Kim, Sae Kyung Joo, Jung Ho Kim, Mee Soo Chang, Byeong Gwan Kim, Kook Lae Lee, Won Kim. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis. Journal of Hepatology 2017; 66(1) doi: 10.1016/j.jhep.2016.08.019
|
| 29 |
Jiu Chen, Peng Gong, Jun Xie. Effects of exercise on body composition, fitness, and blood pressure in overweight or obese patients with MASLD: A systematic review and meta-analysis. Digestive and Liver Disease 2025; 57(11) doi: 10.1016/j.dld.2025.08.090
|
| 30 |
Oh Young Kwon, Jin-young Choi, Yeonsoo Jang. The Effectiveness of eHealth Interventions on Lifestyle Modification in Patients With Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-analysis. Journal of Medical Internet Research 2023; 25 doi: 10.2196/37487
|
| 31 |
Shelley E. Keating, Daniel A. Hackett, Helen M. Parker, Kimberley L. Way, Helen T. O'Connor, Amanda Sainsbury, Michael K. Baker, Vivienne H. Chuter, Ian D. Caterson, Jacob George, Nathan A. Johnson. Effect of resistance training on liver fat and visceral adiposity in adults with obesity: A randomized controlled trial. Hepatology Research 2017; 47(7) doi: 10.1111/hepr.12781
|
| 32 |
Christian von Loeffelholz, Johannes Roth, Sina Coldewey, Andreas Birkenfeld. The Role of Physical Activity in Nonalcoholic and Metabolic Dysfunction Associated Fatty Liver Disease. Biomedicines 2021; 9(12) doi: 10.3390/biomedicines9121853
|
| 33 |
Shira Zelber-Sagi, Justyna Godos, Federico Salomone. Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials. Therapeutic Advances in Gastroenterology 2016; 9(3) doi: 10.1177/1756283X16638830
|
| 34 |
Ahmad Mahdi Ahmad, Heba Mohammed Ali. Comparative effects of two exercise training programs on health-related quality of life in middle-aged women with non-alcoholic fatty liver disease. Advances in Rehabilitation 2020; 34(4) doi: 10.5114/areh.2020.100186
|
| 35 |
Xiao-Ni Chai, Bing-Qian Zhou, Ni Ning, Ting Pan, Fan Xu, Si-Han He, Ni-Ni Chen, Mei Sun. Effects of lifestyle intervention on adults with metabolic associated fatty liver disease: A systematic review and meta-analysis. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1081096
|
| 36 |
Miikka-Juhani Honka, Marco Bucci, Jonathan Andersson, Ville Huovinen, Maria Angela Guzzardi, Samuel Sandboge, Nina Savisto, Minna K. Salonen, Robert M. Badeau, Riitta Parkkola, Joel Kullberg, Patricia Iozzo, Johan G. Eriksson, Pirjo Nuutila. Resistance training enhances insulin suppression of endogenous glucose production in elderly women. Journal of Applied Physiology 2016; 120(6) doi: 10.1152/japplphysiol.00950.2015
|
| 37 |
Christina N Katsagoni, Michael Georgoulis, George V Papatheodoridis, Demosthenes B Panagiotakos, Meropi D Kontogianni. Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis. Metabolism 2017; 68 doi: 10.1016/j.metabol.2016.12.006
|
| 38 |
E. Roeb, A. Canbay, H. Bantel, J. Bojunga, J. de Laffolie, M. Demir, U. W. Denzer, A. Geier, W. P. Hofmann, C. Hudert, T. Karlas, M. Krawczyk, T. Longerich, T. Luedde, M. Roden, J. Schattenberg, M. Sterneck, A. Tannapfel, P. Lorenz, F. Tacke. Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025. Zeitschrift für Gastroenterologie 2022; 60(09) doi: 10.1055/a-1880-2283
|
| 39 |
Updated S2k Clinical Practice Guideline on Non-alcoholic Fatty Liver Disease (NAFLD) issued by the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) – April 2022 – AWMF Registration No.: 021–025. Zeitschrift für Gastroenterologie 2022; 60(09) doi: 10.1055/a-1880-2388
|
| 40 |
Kazem Ranjbar, Hassan Matin Homaie, Mohammad Ali Azarbayjani, Maghsoud Piri. The Effect of Gallic Acid Supplement and Resistance Exercise on the Bio-markers of Liver in Intoxicated Male Rats of Anabolic Steroid. Medical Laboratory Journal 2020; 14(1) doi: 10.29252/mlj.14.1.44
|
| 41 |
Oluwafemi O. Balogun, Emad S. Shaikh, Kathleen E. Corey. Metabolic Steatotic Liver Disease. 2024; doi: 10.1016/B978-0-323-99649-5.00018-2
|
| 42 |
Shelley E. Keating, Angelo Sabag, Kate Hallsworth, Ingrid J. Hickman, Graeme A. Macdonald, Jonathan G. Stine, Jacob George, Nathan A. Johnson. Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A Position Statement from Exercise and Sport Science Australia. Sports Medicine 2023; 53(12) doi: 10.1007/s40279-023-01918-w
|
| 43 |
Ryuki Hashida, Takumi Kawaguchi, Masafumi Bekki, Masayuki Omoto, Hiroo Matsuse, Takeshi Nago, Yoshio Takano, Takato Ueno, Hironori Koga, Jacob George, Naoto Shiba, Takuji Torimura. Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review. Journal of Hepatology 2017; 66(1) doi: 10.1016/j.jhep.2016.08.023
|
| 44 |
Raouf Moradian, Amir Haji Ghasem, Saleh Rahmati, Lida Moradi. Investigation of the simultaneous effect of resistance training and atorvastatin in improving nonalcoholic fatty liver disease in Wistar rats fed high high-fat/fructose diet. Medical Laboratory Journal 2025; 19(3) doi: 10.66224/mlj.19.3.48
|
| 45 |
Irfan Varmazyar, Amir Abbas Monazzami, Mozhgan Moradi, Andrew J McAinch. Effects of 12-weeks resistance training and vitamin E supplementation on aminotransferases, CTRP-2, and CTRP-9 levels in males with nonalcoholic fatty liver disease: a double-blind, randomized trial. BMC Sports Science, Medicine and Rehabilitation 2024; 16(1) doi: 10.1186/s13102-024-00972-9
|
| 46 |
Marie Boyle, Quentin M. Anstee. Evidence‐based Gastroenterology and Hepatology 4e. 2019; doi: 10.1002/9781119211419.ch35
|
| 47 |
Min‐Sun Kwak, Donghee Kim, Goh Eun Chung, Won Kim, Joo Sung Kim. The preventive effect of sustained physical activity on incident nonalcoholic fatty liver disease. Liver International 2017; 37(6) doi: 10.1111/liv.13332
|
| 48 |
S Sherf-Dagan, S Zelber-Sagi, G Zilberman-Schapira, M Webb, A Buch, A Keidar, A Raziel, N Sakran, D Goitein, N Goldenberg, J A Mahdi, M Pevsner-Fischer, N Zmora, M Dori-Bachash, E Segal, E Elinav, O Shibolet. Probiotics administration following sleeve gastrectomy surgery: a randomized double-blind trial. International Journal of Obesity 2018; 42(2) doi: 10.1038/ijo.2017.210
|
| 49 |
Francesca Battista, Andrea Ermolao, Marleen A. van Baak, Kristine Beaulieu, John E. Blundell, Luca Busetto, Eliana V. Carraça, Jorge Encantado, Dror Dicker, Nathalie Farpour‐Lambert, Adriyan Pramono, Alice Bellicha, Jean‐Michel Oppert. Effect of exercise on cardiometabolic health of adults with overweight or obesity: Focus on blood pressure, insulin resistance, and intrahepatic fat—A systematic review and meta‐analysis. Obesity Reviews 2021; 22(S4) doi: 10.1111/obr.13269
|
| 50 |
W. Timothy Garvey, Jeffrey I. Mechanick, Elise M. Brett, Alan J. Garber, Daniel L. Hurley, Ania M. Jastreboff, Karl Nadolsky, Rachel Pessah-Pollack, Raymond Plodkowski. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity. Endocrine Practice 2016; 22 doi: 10.4158/EP161365.GL
|
| 51 |
Rohit Loomba, Helena Cortez-Pinto. Exercise and improvement of NAFLD: Practical recommendations. Journal of Hepatology 2015; 63(1) doi: 10.1016/j.jhep.2015.03.009
|
| 52 |
Thomas Marjot, Ahmad Moolla, Jeremy F Cobbold, Leanne Hodson, Jeremy W Tomlinson. Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and Management. Endocrine Reviews 2020; 41(1) doi: 10.1210/endrev/bnz009
|
| 53 |
Mathias Plauth, Lars Bechmann, Donata Grajecki, Felix Gundling, Ludwig Kramer, Andreas E. Kremer, Monika Rau, Andrea Schneider, Frank Tacke, Ingo van Thiel. S2k-Leitlinie Klinische Ernährung in der Hepatologie. Aktuelle Ernährungsmedizin 2024; 49(04) doi: 10.1055/a-2338-1144
|
| 54 |
Andrea Gonzalez, Mayalen Valero-Breton, Camila Huerta-Salgado, Oscar Achiardi, Felipe Simon, Claudio Cabello-Verrugio. Impact of exercise training on the sarcopenia criteria in non-alcoholic fatty liver disease: a systematic review and meta-analysis. European Journal of Translational Myology 2021; doi: 10.4081/ejtm.2021.9630
|
| 55 |
Tian-Tian Zou, Chao Zhang, Yi-Fan Zhou, Yi-Jing Han, Jiao-Jiao Xiong, Xi-Xi Wu, Yong-Ping Chen, Ming-Hua Zheng. Lifestyle interventions for patients with nonalcoholic fatty liver disease: a network meta-analysis. European Journal of Gastroenterology & Hepatology 2018; 30(7) doi: 10.1097/MEG.0000000000001135
|
| 56 |
Michael Romanos, Juan M. Garcia Cordova, Jose Villamarin, Juan D. Pazmino Zurita, Andres Acosta. Obesity and Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD): A Literature Review on Pathophysiology and Treatment. Diabetes, Obesity and Metabolism 2026; 28(S2) doi: 10.1111/dom.70659
|
| 57 |
|
| 58 |
Maureen Whitsett, Lisa B VanWagner. Physical activity as a treatment of non-alcoholic fatty liver disease: A systematic review. World Journal of Hepatology 2015; 7(16): 2041-2052 doi: 10.4254/wjh.v7.i16.2041
|
| 59 |
Ebaa Al Ozairi, Dalal Alsaeed, Dherar Al Roudhan, Mohammed Jalali, Anant Mashankar, Dennis Taliping, Amal Abdulla, Jason M. R. Gill, Naveed Sattar, Paul Welsh, Stuart R. Gray. The effect of home‐based resistance exercise training in people with type 2 diabetes: A randomized controlled trial. Diabetes/Metabolism Research and Reviews 2023; 39(7) doi: 10.1002/dmrr.3677
|
| 60 |
|
| 61 |
C. Moctezuma-Velázquez. Tratamiento actual de la enfermedad por hígado graso no alcohólico. Revista de Gastroenterología de México 2018; 83(2) doi: 10.1016/j.rgmx.2017.10.003
|
| 62 |
Oliver Glass, Akash Radia, William Kraus, Manal Abdelmalek. Exercise Training as Treatment of Nonalcoholic Fatty Liver Disease. Journal of Functional Morphology and Kinesiology 2017; 2(4) doi: 10.3390/jfmk2040035
|
| 63 |
Parvin Farzanegi, Amir Dana, Zeynab Ebrahimpoor, Mahdieh Asadi, Mohammad Ali Azarbayjani. Mechanisms of beneficial effects of exercise training on non‐alcoholic fatty liver disease (NAFLD): Roles of oxidative stress and inflammation. European Journal of Sport Science 2019; 19(7) doi: 10.1080/17461391.2019.1571114
|
| 64 |
Sechang Oh, Natsumi Oshida, Noriko Someya, Tsuyoshi Maruyama, Tomonori Isobe, Yoshikazu Okamoto, Taeho Kim, Bokun Kim, Junichi Shoda. Whole‐body vibration for patients with nonalcoholic fatty liver disease: a 6‐month prospective study. Physiological Reports 2019; 7(9) doi: 10.14814/phy2.14062
|
| 65 |
Chuanli Yu, Congcong Ding, Chao Yu, Huihui Bao, Xiaoshu Cheng. Decoding the fatty liver-hyperuricemia link in the obese and nonobese hypertensive patients: insights from a cohort study. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-80895-0
|
| 66 |
Jiu Chen, Siji Wang, Xianyang Xin, Jun Xie. Effects of exercise interventions on metabolic and hepatic function markers in overweight or obese patients with MASLD: a systematic review and meta-analysis. BMC Gastroenterology 2025; 26(1) doi: 10.1186/s12876-025-04517-3
|
| 67 |
Sheila Maier, Amanda Wieland, Melanie Cree-Green, Kristen Nadeau, Shelby Sullivan, Miguel A. Lanaspa, Richard J. Johnson, Thomas Jensen. Lean NAFLD: an underrecognized and challenging disorder in medicine. Reviews in Endocrine and Metabolic Disorders 2021; 22(2) doi: 10.1007/s11154-020-09621-1
|
| 68 |
Jae Ho Park, Nam-Kyoo Lim, Hyun-Young Park. Protective Effect of Leisure-Time Physical Activity and Resistance Training on Nonalcoholic Fatty Liver Disease: A Nationwide Cross-Sectional Study. International Journal of Environmental Research and Public Health 2022; 19(4) doi: 10.3390/ijerph19042350
|
| 69 |
Ángel Brea, Xavier Pintó, Juan F. Ascaso, Mariano Blasco, Ángel Díaz, Pedro González-Santos, Antonio Hernández-Mijares, Teresa Mantilla, Jesús Millán, Juan Pedro-Botet. Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment (II). The treatment of nonalcoholic fatty liver disease. Clínica e Investigación en Arteriosclerosis (English Edition) 2017; 29(4) doi: 10.1016/j.artere.2017.07.001
|
| 70 |
Yun Chen, Xiaoya Qiao, Xinyi Zou, Kai Xu, Zhongke Gu, Gangrui Chen, Jiansong Dai. Resistance training for metabolic dysfunction-associated steatotic liver disease:a systematic review and meta-analysis. Frontiers in Physiology 2026; 16 doi: 10.3389/fphys.2025.1679094
|
| 71 |
Nuria Perez-Diaz-del-Campo, Gabriele Castelnuovo, Arianna Ferro, Gian Paolo Caviglia, Chiara Rosso, Eleonora Dileo, Marta Guariglia, Angelo Armandi, Francesca Saba, Giorgio Maria Saracco, Federica Barutta, Guglielmo Beccuti, Gabriella Gruden, Zobair M. Younossi, Elisabetta Bugianesi. Impact of Metabolic Dysfunction-Associated Steatotic Liver Disease and Associated Comorbidities on Cognitive and Health-Related Quality-of-Life Outcomes in a Mixed Metabolic Dysfunction-Associated Steatotic Liver Disease-Type 2 Diabetes Mellitus Cohort. American Journal of Gastroenterology 2025; 120(8) doi: 10.14309/ajg.0000000000003594
|
| 72 |
Mariana S. SILVA, Felipe N. SANTOS, Laura S. LAGARES, Rodrigo C. MACEDO, Eric S. BOMFIM, Juliana L. SILVA, Luiz A. ALMEIDA, Iasmyn S. SILVA, Clarcson P. SANTOS. Physical exercise and its effects on liver aminotransferases in non-alcoholic fatty liver disease: a review systematic. Gazzetta Medica Italiana Archivio per le Scienze Mediche 2024; 183(3) doi: 10.23736/S0393-3660.23.05200-2
|
| 73 |
William N. Hannah, Stephen A. Harrison. Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease. Digestive Diseases and Sciences 2016; 61(5) doi: 10.1007/s10620-016-4153-y
|
| 74 |
Sedhunivas R., Chandramohan R.. “Anthropometric measurements and exercise interventions in non-alcoholic fatty liver disease patients”: a literature review. Bulletin of Faculty of Physical Therapy 2024; 29(1) doi: 10.1186/s43161-023-00164-5
|
| 75 |
Lais S Garcêz, Camila R Avelar, Nedja S S Fonseca, Priscila R F Costa, André C Lyra, Carla M Cunha, Rosangela P Jesus, Lucivalda P M Oliveira. Effect of dietary carbohydrate and lipid modification on clinical and anthropometric parameters in nonalcoholic fatty liver disease: a systematic review and meta-analysis. Nutrition Reviews 2021; 79(12) doi: 10.1093/nutrit/nuaa146
|
| 76 |
Susan Kenneally, Joanna H Sier, J Bernadette Moore. Efficacy of dietary and physical activity intervention in non-alcoholic fatty liver disease: a systematic review. BMJ Open Gastroenterology 2017; 4(1) doi: 10.1136/bmjgast-2017-000139
|
| 77 |
Chieh Liu, Chun-Jen Liu. Effects of Exercise Intervention in Subjects with Metabolic Dysfunction-Associated Steatotic Liver Disease. Journal of Obesity & Metabolic Syndrome 2025; 34(3) doi: 10.7570/jomes25028
|
| 78 |
Jiaren Wang, Lin Zeng, Chang Hong, Hao Cui, Weizhen Wang, Hongbo Zhu, Qimei Li, Yan Li, Ruining Li, Jingzhe He, Hong Zhu, Li Liu, Lushan Xiao. Lower creatinine to cystatin C ratio is associated with an increased risk of MASLD: A cross‐sectional and prospective study of 368,634 UK Biobank participants. Clinical Endocrinology 2024; 100(2) doi: 10.1111/cen.14990
|
| 79 |
Andrea Gonzalez, Mayalen Valero-Breton, Camila Huerta-Salgado, Oscar Achiardi, Felipe Simon, Claudio Cabello-Verrugio. Impact of exercise training on the sarcopenia criteria in non-alcoholic fatty liver disease: a systematic review and meta-analysis. European Journal of Translational Myology 2021; doi: 10.4081/ejtm.2020.9630
|
| 80 |
Lorenzo A. Orci, Karim Gariani, Graziano Oldani, Vaihere Delaune, Philippe Morel, Christian Toso. Exercise-based Interventions for Nonalcoholic Fatty Liver Disease: A Meta-analysis and Meta-regression. Clinical Gastroenterology and Hepatology 2016; 14(10) doi: 10.1016/j.cgh.2016.04.036
|
| 81 |
Rola S. Zeidan, Simon Reinhard, Anna Picca, Emanuele Marzetti, Christiaan Leeuwenburgh, James F. Collins, Stephen D. Anton. Is Ferroptosis the Mechanistic Bridge Connecting Iron Dysregulation to Muscle Wasting and Functional Decline in Aging?. Aging Cell 2026; 25(2) doi: 10.1111/acel.70367
|
| 82 |
Daniele Gorski Medeiros, Luis Fernando Ferreira, Jessica da Silva Lamp, Luis Henrique Telles da Rosa. The impact of resistance training in patients diagnosed with metabolic dysfunction-associated steatotic liver disease: a systematic review. European Journal of Gastroenterology & Hepatology 2025; 37(2) doi: 10.1097/MEG.0000000000002887
|
| 83 |
Ariel Vivero, Manuel Ruz, Matías Rivera, Karen Miranda, Camila Sacristán, Alejandra Espinosa, Juana Codoceo, Jorge Inostroza, Karla Vásquez, Álvaro Pérez, Diego García-Díaz, Miguel Arredondo. Zinc Supplementation and Strength Exercise in Rats with Type 2 Diabetes: Akt and PTP1B Phosphorylation in Nonalcoholic Fatty Liver. Biological Trace Element Research 2021; 199(6) doi: 10.1007/s12011-020-02324-3
|
| 84 |
Amel Ait Boudaoud, Claire Rives-Lange, Jean François Perregaux, Alina Radu, Diane Messager-Josipowicz, Charles Barsamian, Claire Carette, Sébastien Czernichow. Interventions nutritionnelles dans la prise en charge de la stéatose et la stéatohépatite non alcoolique. La Presse Médicale 2019; 48(12) doi: 10.1016/j.lpm.2019.10.026
|
| 85 |
Shelley E Keating, Jacob George, Nathan A Johnson. The benefits of exercise for patients with non-alcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2015; 9(10) doi: 10.1586/17474124.2015.1075392
|
| 86 |
Shu-ting Wang, Jing Zheng, He-wei Peng, Xiao-lin Cai, Xin-ting Pan, Hui-quan Li, Qi-zhu Hong, Xian-E Peng. Physical activity intervention for non-diabetic patients with non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01204-3
|
| 87 |
Jonathan G. Stine, Ian R. Schreibman, Alison J. Faust, Jessica Dahmus, Benjamin Stern, Christopher Soriano, Gloriany Rivas, Breianna Hummer, Scot R. Kimball, Nate R. Geyer, Vernon M. Chinchilli, Rohit Loomba, Kathryn Schmitz, Christopher Sciamanna. NASHFit: A randomized controlled trial of an exercise training program to reduce clotting risk in patients with NASH. Hepatology 2022; 76(1) doi: 10.1002/hep.32274
|
| 88 |
Sara Paola Mambrini, Antonio Grillo, Santo Colosimo, Francesco Zarpellon, Giorgia Pozzi, Davide Furlan, Gabriele Amodeo, Simona Bertoli. Diet and physical exercise as key players to tackle MASLD through improvement of insulin resistance and metabolic flexibility. Frontiers in Nutrition 2024; 11 doi: 10.3389/fnut.2024.1426551
|
| 89 |
Thomas Marjot, Matthew J. Armstrong, Jonathan G. Stine. Skeletal muscle and MASLD: Mechanistic and clinical insights. Hepatology Communications 2025; 9(6) doi: 10.1097/HC9.0000000000000711
|
| 90 |
Yilun Xu, Yaqi Guan, Wenyi Jin, Li Ding, Jinming Wu. WITHDRAWN: Higher appendicular skeletal muscle mass percentage is an independent protective factor for non-alcoholic steatohepatitis and significant fibrosis in male with NAFLD. Gastroenterología y Hepatología 2020; doi: 10.1016/j.gastrohep.2020.05.020
|
| 91 |
Su Hang, Lan Xiaoyu, Wang Jue, Lu Yingli, Zhang Li. Effects of resistance training and aerobic training on improving the composition of middle-aged adults with obesity in an interventional study. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-11076-w
|
| 92 |
Hassan A. Abdou, Saied A. Omar. The Liver-Heart Axis: A Narrative Review of Clinical Implications of the MASLD Redefinition for Internists. ASIDE Gastroenterology 2026; 2(2) doi: 10.71079/ASIDE.GI.031826446
|
| 93 |
Ambrin Farizah Babu, Susanne Csader, Johnson Lok, Carlos Gómez-Gallego, Kati Hanhineva, Hani El-Nezami, Ursula Schwab. Positive Effects of Exercise Intervention without Weight Loss and Dietary Changes in NAFLD-Related Clinical Parameters: A Systematic Review and Meta-Analysis. Nutrients 2021; 13(9) doi: 10.3390/nu13093135
|
| 94 |
Tuva Marie Lindstad, Shirin Pourteymour, Sindre Lee-Ødegård, Christian André Drevon, Frode Amador Norheim. Structured Exercise Interventions and Hepatic–Metabolic Outcomes in Adults with MASLD: A Narrative Review of Randomized Controlled Trials. International Journal of Molecular Sciences 2026; 27(7) doi: 10.3390/ijms27072941
|
| 95 |
Junjie Xiao, Yihua Bei, Jingqi Liu, Jasmina Dimitrova‐Shumkovska, Dapeng Kuang, Qiulian Zhou, Jin Li, Yanning Yang, Yang Xiang, Fei Wang, Changqing Yang, Wenzhuo Yang. miR‐212 downregulation contributes to the protective effect of exercise against non‐alcoholic fatty liver via targeting FGF‐21. Journal of Cellular and Molecular Medicine 2016; 20(2) doi: 10.1111/jcmm.12733
|
| 96 |
Pankaj Puri, Narendra Kotwal. An Approach to the Management of Diabetes Mellitus in Cirrhosis: A Primer for the Hepatologist. Journal of Clinical and Experimental Hepatology 2022; 12(2) doi: 10.1016/j.jceh.2021.09.010
|
| 97 |
Mohammad Mahmoudi Azar, Matin Shirazinia, Mohsen Nematy, Vafa Baradaran Rahimi, Motahare Bateni, Fateme Tafaghodi Piadeh Gheibi, Farnood Rajabzadeh, Ladan Goshayeshi, Sara Honari, Mehran Mottahedi, Vahid Reza Askari. The effects of ellagic acid in metabolic dysfunction-associated steatotic liver disease (MASLD) patients: a randomized, add-on, double-blind, controlled trial. Inflammopharmacology 2025; 33(9) doi: 10.1007/s10787-025-01919-3
|
| 98 |
Muhammad Ahsan Asif, Saad Masood, Syed Muhammad Ali Akbar, Muhammad Hamza Khalid, Abdul Rehman, Mahnoor Imran, Arooba Suhaib, Muhammad Ans Asif, Azeem Khalid, Muhammad Sohaib, Arkadeep Dhali, Dushyant Singh Dahiya, Hassam Ali. Exercise Versus Standard Therapy in Steatotic Liver Disease Spectrum: A Systematic Review, Meta-Analysis, and Meta-Regression. Journal of Clinical Medicine 2026; 15(14) doi: 10.3390/jcm15145737
|
| 99 |
Georgios Tsamos, Dimitra Vasdeki, Theocharis Koufakis, Vassiliki Michou, Kali Makedou, Georgios Tzimagiorgis. Therapeutic Potentials of Reducing Liver Fat in Non-Alcoholic Fatty Liver Disease: Close Association with Type 2 Diabetes. Metabolites 2023; 13(4) doi: 10.3390/metabo13040517
|
| 100 |
Yuanyuan Chen, Rongqin Liu, Renli Huang, Qinwei Li, Yu Zhang. Mechanistic insights and evidence-based management of metabolic dysfunction-associated steatotic liver disease (MASLD; formerly NAFLD) through combined diet and exercise interventions: an evidence-based narrative review. Journal of Clinical Biochemistry and Nutrition 2026; 79(1) doi: 10.3164/jcbn.25-259
|
| 101 |
Mariangela Rondanelli, Clara Gasparri, Claudia Razza, Cinzia Ferraris, Simone Perna, Ilaria Ferrarotti, Angelo Guido Corsico. Practical dietary advices for subjects with alpha-1 antitrypsin deficiency. Biomedicine & Pharmacotherapy 2023; 163 doi: 10.1016/j.biopha.2023.114753
|
| 102 |
Elke Roeb. Diagnostic and Therapy of Nonalcoholic Fatty Liver Disease: A Narrative Review. Visceral Medicine 2022; 38(2) doi: 10.1159/000519611
|
| 103 |
Veera Houttu, Ulrika Boulund, Aldo Grefhorst, Maarten R. Soeters, Sara-Joan Pinto-Sietsma, Max Nieuwdorp, Adriaan G. Holleboom. The role of the gut microbiome and exercise in non-alcoholic fatty liver disease. Therapeutic Advances in Gastroenterology 2020; 13 doi: 10.1177/1756284820941745
|
| 104 |
Mingming Huang, Jiafa Yang, Yihao Wang, Jian Wu. Comparative efficacy of different exercise modalities on metabolic profiles and liver functions in non-alcoholic fatty liver disease: a network meta-analysis. Frontiers in Physiology 2024; 15 doi: 10.3389/fphys.2024.1428723
|
| 105 |
Nuria Perez-Diaz-del-Campo, Bertha Araceli Marin-Alejandre, Irene Cantero, J. Ignacio Monreal, Mariana Elorz, José Ignacio Herrero, Alberto Benito-Boillos, Jose I. Riezu-Boj, Fermín I. Milagro, Josep A. Tur, J. Alfredo Martinez, Itziar Abete, M. Angeles Zulet. Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) Study. European Journal of Nutrition 2021; 60(6) doi: 10.1007/s00394-020-02476-x
|
| 106 |
Fatemeh Kazeminasab, Motahareh Mohebinejad, Mohammad Hossein Mahboobi, Maedeh Nojoumi, Saba Belyani, Reza Bagheri, Fred Dutheil. Combined exercise training and dietary interventions versus independent effect of exercise on ectopic fat in individuals with overweight and obesity: a systematic review, meta‐analysis, and meta-regression. Journal of the International Society of Sports Nutrition 2025; 22(1) doi: 10.1080/15502783.2025.2528534
|
| 107 |
Tiziana Fernández, Macarena Viñuela, Catalina Vidal, Francisco Barrera, Pavel Strnad. Lifestyle changes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis. PLOS ONE 2022; 17(2) doi: 10.1371/journal.pone.0263931
|
| 108 |
Sunyoung Kang, Min Kyong Moon, Won Kim, Bo Kyung Koo. Association between muscle strength and advanced fibrosis in non‐alcoholic fatty liver disease: a Korean nationwide survey. Journal of Cachexia, Sarcopenia and Muscle 2020; 11(5) doi: 10.1002/jcsm.12598
|
| 109 |
Zobair M. Younossi, Shira Zelber-Sagi, Linda Henry, Lynn H. Gerber. Lifestyle interventions in nonalcoholic fatty liver disease. Nature Reviews Gastroenterology & Hepatology 2023; 20(11) doi: 10.1038/s41575-023-00800-4
|
| 110 |
Dirk J. van der Windt, Vikas Sud, Hongji Zhang, Allan Tsung, Hai Huang. The Effects of Physical Exercise on Fatty Liver Disease. Gene Expression 2018; 18(2) doi: 10.3727/105221617X15124844266408
|
| 111 |
Dimitrios Papandreou, Eleni Andreou. Role of diet on non-alcoholic fatty liver disease: An updated narrative review. World Journal of Hepatology 2015; 7(3): 575-582 doi: 10.4254/wjh.v7.i3.575
|
| 112 |
Hao Su, Dongsen Liu, Jia Shao, Yinuo Li, Xiaoxia Wang, Qi Gao. Aging Liver: Can Exercise be a Better Way to Delay the Process than Nutritional and Pharmacological Intervention? Focus on Lipid Metabolism. Current Pharmaceutical Design 2020; 26(39) doi: 10.2174/1381612826666200605111232
|
| 113 |
Rosamar E.F. Rezende, Sebastião M.B. Duarte, Jose T. Stefano, Hamilton Roschel, Bruno Gualano, Ana L. de Sá Pinto, Denise C.P. Vezozzo, Flair J. Carrilho, Claudia P. Oliveira. Randomized clinical trial: benefits of aerobic physical activity for 24 weeks in postmenopausal women with nonalcoholic fatty liver disease. Menopause 2016; 23(8) doi: 10.1097/GME.0000000000000647
|
| 114 |
N A Smart, N King, J R McFarlane, P L Graham, G Dieberg. Effect of exercise training on liver function in adults who are overweight or exhibit fatty liver disease: a systematic review and meta-analysis. British Journal of Sports Medicine 2018; 52(13) doi: 10.1136/bjsports-2016-096197
|
| 115 |
Jing Zeng, Jian‐Gao Fan, Sven M. Francque. Therapeutic management of metabolic dysfunction associated steatotic liver disease. United European Gastroenterology Journal 2024; 12(2) doi: 10.1002/ueg2.12525
|
| 116 |
Yongqing Guo, Xianyang Xin, Pei Liu. The impact of long-term exercise on liver function, fatty liver progression, and related metabolic markers in NAFLD patients: a meta-analysis of randomized controlled trials. Frontiers in Nutrition 2026; 13 doi: 10.3389/fnut.2026.1731510
|
| 117 |
Hadi Goudarzi, Ali Heidarianpour, Maryam Keshvari. The Effect of 12 Weeks of Combined Training on the Serum Levels of Liver Enzymes in Men with Non-Alcoholic Fatty Liver Disease. Journal of Arak University of Medical Sciences 2024; 27(2) doi: 10.61186/jams.27.2.106
|
| 118 |
Mousa Khalafi, Saeid Fatolahi, Michael E. Symonds, Sara K. Rosenkranz, Farnaz Dinizadeh, Alexios Batrakoulis. Comparative Efficacy of Different Exercise Interventions on Intrahepatic Lipid Content, Glucose Homeostasis, and Liver Function in Adults With and Without Nonalcoholic Fatty Liver Disease: A Systematic Review With Pairwise and Network Meta‐Analyses. Obesity Reviews 2026; 27(4) doi: 10.1111/obr.70052
|
| 119 |
J. A. Russell-Guzmán, L. Karachon, T. A. Gacitúa, A. Freundlich, C. E. Poblete-Aro, R. Rodrigo. Role of exercise in the mechanisms ameliorating hepatic steatosis in non-alcoholic fatty liver disease. Sport Sciences for Health 2018; 14(3) doi: 10.1007/s11332-018-0459-9
|
| 120 |
Robinson Ramírez-Vélez, Mikel Izquierdo, Jorge Correa-Bautista, Alejandra Tordecilla-Sanders, María Correa-Rodríguez, Jacqueline Schmidt Rio-Valle, Emilio González-Jiménez, Katherine González-Ruíz. Grip Strength Moderates the Association between Anthropometric and Body Composition Indicators and Liver Fat in Youth with an Excess of Adiposity. Journal of Clinical Medicine 2018; 7(10) doi: 10.3390/jcm7100347
|
| 121 |
Shira Zelber-Sagi, Shiran Bord, Gali Dror-Lavi, Matthew Lee Smith, Samuel D Towne Jr, Assaf Buch, Muriel Webb, Hanny Yeshua, Assy Nimer, Oren Shibolet. Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients. World Journal of Gastroenterology 2017; 23(10): 1881-1890 doi: 10.3748/wjg.v23.i10.1881
|
| 122 |
Gabriel Scarlat, Bassil Dona, Mihai Cârstea, Marilena Stoian. Insights into Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. Internal Medicine 2022; 19(1) doi: 10.2478/inmed-2022-0198
|
| 123 |
Soheila Jangjo-Borazjani, Maryam Dastgheib, Efat Kiyamarsi, Roghayeh Jamshidi, Saleh Rahmati-Ahmadabad, Masoumeh Helalizadeh, Roya Iraji, Stephen M Cornish, Shiva Mohammadi-Darestani, Zohreh Khojasteh, Mohammad Ali Azarbayjani. Effects of resistance training and nigella sativa on type 2 diabetes: implications for metabolic markers, low-grade inflammation and liver enzyme production. Archives of Physiology and Biochemistry 2023; 129(4) doi: 10.1080/13813455.2021.1886117
|
| 124 |
Alia Hadefi, Marianna Arvanitakis, Eric Trépo, Shira Zelber‐Sagi. Dietary strategies in non‐alcoholic fatty liver disease patients: From evidence to daily clinical practice, a systematic review. United European Gastroenterology Journal 2023; 11(7) doi: 10.1002/ueg2.12443
|
| 125 |
José Tadeu Stefano, Sebastião Mauro Bezerra Duarte, Renato Gama Ribeiro Leite Altikes, Claudia P. Oliveira. Non-pharmacological management options for MAFLD: a practical guide. Therapeutic Advances in Endocrinology and Metabolism 2023; 14 doi: 10.1177/20420188231160394
|
| 126 |
C. Moctezuma-Velázquez. Current treatment for non-alcoholic fatty liver disease. Revista de Gastroenterología de México (English Edition) 2018; 83(2) doi: 10.1016/j.rgmxen.2018.05.014
|
| 127 |
Tom Cormier. Exercise Programming for Nonalcoholic Fatty Liver Disease. Strength & Conditioning Journal 2019; 41(4) doi: 10.1519/SSC.0000000000000462
|